PubMed · 8476991
Complement activation by polymethyl methacrylate minimized by end-point heparin attachment.
Abstract
After intraocular lens implantation, despite good clinical results, many cataract patients develop a chronic uveitis, caused by an inflammatory response to the implant. One way to improve the biocompatibility of the intraocular lens is to modify the surface by end-point heparin attachment. This study shows that complement activation caused by poly(methyl methacrylate) can be diminished by end-point heparin attachment, as demonstrated by a significant reduction in the generation of C3a and fluid phase terminal complement complexes. It suggests that assessment of complement activation is a good indicator of the biocompatibility of intraocular lenses.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M Pekna, R Larsson, B Formgren, U R Nilsson, B Nilsson. 1993. Complement activation by polymethyl methacrylate minimized by end-point heparin attachment.. https://doi.org/10.1016/0142-9612(93)90022-t
Cite the original work for its findings. Save a collection to share your selection of sources.